However, it remains to be elucidated whether SHIP1 deficiency leads to more pronounced changes in skeletal development and homeostasis in pathological conditions such as post-menopausal osteoporosis with underlying chronic low-level inflammation. Here, INPP5D is linked to osteoporosis.